Clinical Trial

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Name: Glofitamab Combined With CAR-T Therapy in R/R DLBCL — clinical trial record (NCT07326371)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a single-center, open-label, prospective study aimed at evaluating the efficacy and safety of Glofitamab combined with CAR-T therapy in patients with high-risk relapsed/refractory large B-cell lymphoma.

Trial Details

NCT Number	NCT07326371
Lead Sponsor	Ruijin Hospital
Conditions	DLBCL - Diffuse Large B Cell Lymphoma
Enrollment	24 participants
Start Date	2026-03
Primary Completion	2027-07 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2026-01-08